A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy

Resistance to platinum and taxane adjuvant chemotherapy (ACT) is the main cause of the recurrence and poor prognosis of high-grade serous ovarian cancer (HGS-OvCa) patients receiving platinum-taxane ACT after surgery. However, currently reported quantitative transcriptional signatures, which are com...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yixin, Zhang, Zheyang, Li, Tianhao, Li, Xin, Zhang, Sainan, Li, Ying, Zhao, Wenyuan, Gu, Yunyan, Guo, Zheng, Qi, Lishuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813654/
https://www.ncbi.nlm.nih.gov/pubmed/31681618
http://dx.doi.org/10.3389/fonc.2019.01094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813654/
https://www.ncbi.nlm.nih.gov/pubmed/31681618
http://dx.doi.org/10.3389/fonc.2019.01094

Ejemplares similares